Our Purpose, Value, and Heritage
Guided by our purpose and core values, APL is committed to making healthcare more accessible and sustainable in Indonesia.
Our purpose of making healthcare accessible in Indonesia lies at the heart of everything we do. It drives our forward-looking mindset to innovate, up-hold the highest standard of excellence and integrity, and create a lasting, sustainable impact for future generations. Through our capabilities in healthcare Distribution, Commercialization, Clinical Trial Support and Patient Care, we are committed to improving health outcomes in the communities we serve.
APL’s core values are foundational to our promise as an organization. These values inspire us to always put the needs and well-being of the people and communities we serve first.
Our Values
We Uphold the Highest Standards of Integrity and Excellence
We Embrace a Growth Mindset
We Collaborate for Shared Success
The APL Story
Beginning in 1985, APL was established as a leading independent pharmaceutical distributor, supporting two multinational pharmaceutical manufacturers. Our first warehouse, "Gedung Biru" in Pulogadung, Jakarta symbolizes our spirit of dedication and commitment to delivering essential healthcare products throughout Indonesia.
Driven by a focus on innovation, adaptability, and partnership, APL has grown into a US$1.1 billion enterprise, serving more than 50 global pharmaceutical partners and reaching over 67,000 customers across Indonesia.
1985
After completing his studies in Zurich, Switzerland, Dr. Willem B. Wanandi returned to Indonesia with a vision to expand access to quality healthcare. That same year, APL was founded with a clear purpose to strengthen healthcare distribution across the nation.
1999
APL was recognized as a leading independent pharmaceutical distributor in Indonesia, setting new benchmarks for operational excellence and industry standards.
2001
APL accelerated its digital transformation by implementing SAP and launching advanced information systems, including the Executive Information System (EIS) and an integrated call center platform. These innovations enhanced transparency, real-time report, and connectivity for APL's partner nationwide.
2005
APL entered a new chapter of growth by becoming a joint venture with Zuellig Pharma Group, the largest healthcare services group in Asia.
2018
APL expanded beyond distribution into Commercialization services through strategic acquisitions of PT Metro Drug Indonesia and APL Pharmalink, reinforcing its commitment to delivering end-to-end healthcare solutions. In the same year, we collaborated with IBM to advanced data-drive innovation and digital capabilities.
2019
APL reaffirmed its leadership in healthcare innovation by hosting its largest exhibition to date, showcasing our digital ecosystem and advancing the healthcare 4.0 agenda in Indonesia.
2020
APL inaugurated its National Distribution Center in Cikarang, West Java. Spanning over 39,930 square meter, NDC is Indonesia's first and largest world-class pharmaceutical distribution center.
Present
APL continutes to build on its legacy as a trusted partner in healthcare. Committed to sustainability, APL has earned consecutive EcoVadis Platinum ratings for its environmental, social, and governance practices, reflecting its dedication to shaping a healthier and more resilient future for Indonesia.